Nuzenio

Tradingview Arcus Biosciences

Tradingview Arcus Biosciences entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Arcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $38.25, Implies 38% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:44 GMTArcus Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:37:26 GMTArcus Biosciences 2Q 2026: Revenue $41M, EPS ($0.72) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTRCUS: Advanced casdatifan in ccRCC, secured new partnerships, and maintained strong cash runway - TradingViewTradingView · Wed, 05 Aug 2026 20:14:38 GMTArcus Biosciences reports Q2 2026 results: $41M revenue, $775M cash, $91M net loss - TradingViewTradingView · Wed, 05 Aug 2026 20:13:01 GMTBRIEF-Arcus Biosciences Q2 Pretax Profit USD -91 Million - TradingViewTradingView · Wed, 05 Aug 2026 20:06:02 GMTWeekly Recap: ccRCC trial cohort additions and Q2 2026 results call - TradingViewTradingView · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 17:20:44 GMTArcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $38.25, Implies 38% Upside - TradingView
Wed, 05 Aug 2026 21:37:26 GMTArcus Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 20:26:35 GMTArcus Biosciences 2Q 2026: Revenue $41M, EPS ($0.72) — 10-Q Summary - TradingView
Wed, 05 Aug 2026 20:14:38 GMTRCUS: Advanced casdatifan in ccRCC, secured new partnerships, and maintained strong cash runway - TradingView
Wed, 05 Aug 2026 20:13:01 GMTArcus Biosciences reports Q2 2026 results: $41M revenue, $775M cash, $91M net loss - TradingView
Wed, 05 Aug 2026 20:06:02 GMTBRIEF-Arcus Biosciences Q2 Pretax Profit USD -91 Million - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Arcus Biosciences.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.